Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility-Reference-Cited by-同舟云学术

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

Published:2012-12-07 Issue:3 Volume:34 Page:605-611
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Capasso Mario,Diskin Sharon J.,Totaro Francesca,Longo Luca,Mariano Marilena De,Russo Roberta,Cimmino Flora,Hakonarson Hakon,Tonini Gian Paolo,Devoto Marcella,Maris John M.,Iolascon Achille

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/34/3/605/17292686/bgs380.pdf

Reference20 articles.

1. Recent advances in neuroblastoma;Maris;N. Engl. J. Med,2010

2. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report;Cohn;J. Clin. Oncol,2009

3. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma;Maris;N. Engl. J. Med,2008

4. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma;Capasso;Nat. Genet,2009

5. Integrative genomics identifies LMO1 as a neuroblastoma oncogene;Wang;Nature,2011

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study;BMC Cancer;2024-06-27

2. Correlation of BARD1 gene polymorphisms with risk of neuroblastoma: a meta-analysis;Nucleosides, Nucleotides & Nucleic Acids;2024-04-15

3. The causal relationship between gut microbiota and neuroblastoma: a bidirectional Mendelian randomization analysis and meta-analysis;Microbiology Spectrum;2024-04-02

4. Causal Relationship between Sex Hormone-Binding Globulin and Risk of Neuroblastoma: A Bidirectional Two-Sample Mendelian Randomization Study;Cancer Epidemiology, Biomarkers & Prevention;2024-03-26

5. Genetic Predisposition;Pediatric Oncology;2024